losing hair on tirzepatide In this week's episode of the Evidence Based Podcast, I delve into a fascinating study from JAAD Case Reports, which explores the potential benefits of the diabetes drug terzepatide (Mounjaro, Zepbound) Does Mounjaro(Tirzepatide) Cause Hair Loss?:

Daily administration would produce accumulating plasma levels far beyond the studied range, dramatically increasing side effects without proportional benefit

This study was limited in scope: Conducted on 24 rats, not humans Administered a single dose Designed only to demonstrate that some absorption is possible Importantly, the study itself includes this disclaimer: This proof-of-concept study is not intended to provide guidance on the sublingual dosing of semaglutide in humans, or dosing conversion from other forms to sublingual administration. This means the only research behind these products cannot confirm whether they work in humans or provide guidance on appropriate dosing

Tirzepatide for managing overweight and obesity PDF guidance (TA1026)

How do I administer the injection

There is no UK Summary of Product Characteristics (SmPC) for retatrutide, and no authorised clinical dosing or reconstitution guidance exists